Alpha-and beta-synucleins mRNA expression in lymphocytes of schizophrenia patients

Genetic Testing and Molecular Biomarkers

Volumn 14, Issue 5, 2010, Pages 725-729

  Noori Daloii, Mohammad Reza ^a   Kheirollahi, Majid ^a   Mahbod, Parinaz ^a   Mohammadi, Fatemeh ^b   Astaneh, Ali Nazeri ^c   Zarindast, Mohammad Reza ^a   Azimi, Cyrus ^a   Mohammadi, Mohammad Reza ^d  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF TEHRAN   (Iran)

^c UNIVERSITY OF SOCIAL WELFARE AND REHABILITATION SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; BETA SYNUCLEIN; COMPLEMENTARY DNA; MESSENGER RNA;

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE EXPRESSION; HUMAN; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SCHIZOPHRENIA;

ADULT; AGED; ALPHA-SYNUCLEIN; BETA-SYNUCLEIN; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; RNA, MESSENGER; SCHIZOPHRENIA;

EID: 78650109874     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2010.0050     Document Type: Article

References (30)

1. Adamczyk A, Solecka J, Strosznajder JB (2005) Expression of alpha-synuclein in different brain parts of adult and aged rats. J Physiol Pharmacol 56:29-37.
2. American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders, 4th edition, text revised. American Psychiatric Association, Washington, DC.
3. American Psychiatric Association (2002) Diagnostic and Statistical Manual of Mental Disorders, 4th edition, text revised. American Psychiatric Association, Washington, DC.
4. Bhugra D (2006) The global prevalence of schizophrenia. PLOS Med 2:372-373.
5. Cabin DE, Shimazu K, Murphy D, et al. (2002) Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking a-synuclein. J Neurosci 22:8797-8807.
6. Castle D, Wesseley S, Der G, Murray R (1991) The incidence of operationally defined schizophrenia in Camberwell 1965-84. Br J Psychiatry 159:790-794.
7. Chiba-Falek O, Lopez GJ, Nussbaum RL (2006) Levels of alpha-synuclein mRNA in sporadic Parkinson disease patients. Mov Disord 21:1703-1708.
8. Chua CE, Tang BL (2006) Alpha-synuclein and Parkinson's disease: the first roadblock. J Cell Mol Med 10:837-846.
9. Cullen K, Kumra S, Regan J (2008) Atypical antipsychotics for treatment of schizophrenia spectrum disorders. In: Psychiatric Times. Vol. 25, No. 3, www.psychiatrictimes.com/display/article/10168/1147536.
10. Dauer W, Ho CC (2010) The biology and pathology of the familial Parkinson's disease protein LRRK2. Mov Disord 25 Suppl 1:S40-S43.
11. Funayama M, Li Y, Tsoi TH, et al. (2008) Familial parkinsonism with digenic Parkin and PINK1 mutations. Mov Disord 23:1461-1465.
12. Galvin JE, Uryu K, Lee VM-Y, Trojanowski JQ (1999) Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains a-, b-, andg-synuclein. Proc Natl Acad Sci USA 96:13450-13455.
13. George JM (2001) The synucleins. Genome Biol 3:reviews 3002.3001-3002.3006.
14. Gitler AD, Shorter J (2007) Prime Time for a-Synuclein. J Neu-rosci 27:2433-2434.
15. Gogos JA, Gerber DJ (2006) Schizophrenia susceptibility genes: emergence of positional candidates and future directions. Trends Pharmacol Sci 27:226-233.
16. Goldner E, Hsu L, Waraich P, Somers J (2002) Prevalence and incidence studies of schizophrenic disorders: a systematic review of the literature. Can J Psychiatry 47:833-843.
17. Hashimoto M, Bar-On P, Ho G, et al. (2004) Beta-synuclein regulates Akt activity in neuronal cells. A possible neuroprotec-tion in Parkinson's disease. J Biol Chem 279:23622-23629.
18. Hashimoto M, Rockenstein E, Mante M, et al. (2001) Beta-synuclein inhibits alpha-synuclein aggregation: a possible role as an anti-parkinsonian factor. Neuron 25:213-223.
19. Hassett A, Ames D, Chiu E (2005) Psychosis in the Elderly. Taylor and Francis, London.
20. Karayiorgou M, Gogos JA (1997) A turning point in schizophrenia genetics. Neuron 19:967-979.
21. Kazantsev AG, Kolchinsky AM (2008) Central role of a-synuclein oligomers in neurodegeneration in Parkinson disease. Arch Neurol 65:1577-1581.
22. Kingsbury AE, Daniel SE, Sangha H, et al. (2004) Alteration in alpha-synuclein mRNA expression in Parkinson's disease. Mov Disord 19:162-170.
23. Kumra S, Shaw M, Merka P, et al. (2001) Childhood-onset schizophrenia: research update. Can J Psychiatry 46:923-930.
24. Li J, Henning Jensen P, Dahlstrom A (2002) Differential localization of alpha-, beta-and gamma-synucleins in the rat CNS. Neuroscience 113:463-478.
25. Pankratz N, Pauciulo MW, Elsaesser VE, et al. (2006) Mutations in DJ-1 are rare in familial Parkinson disease. Neurosci Lett 408:209-213.
26. Pennington K, Dicker P, Dunn MJ, Cotter DR (2008) Proteomic analysis reveals protein changes within layer 2 of the insular cortex in schizophrenia. Proteomics 8:5097-5107.
27. Polymeropoulos MH, Lavedan C, Leroy E, et al. (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276:2045-2047.
28. Tan EK, Chandran VR, Fook-Chong S (2005) Alpha-synuclein mRNA expression in sporadic Parkinson's disease. Mov Disord 20:620-623.
29. Verca MSB, Bahi A, Boyer F, et al. (2003) Distribution of alpha-and gamma-synucleins in the adult rat brain and their modification by high-dose cocaine treatment. Eur J Neurosci 18:1923-1938.
30. Yu S, Li X, Liu G, et al. (2007) Extensive nuclear localization of alpha-synuclein in normal rat brain neurons revealed by a novel monoclonal antibody. Neuroscience 145:539-555.